In the first, we performed IP experiments using 500 μg of NE from NTERA-2 and somatic cancer cells and with 5 anti-Nanog Abs, i.e., eBioscience mAb, Kamiya pAb, CS Rb mAb, SC pAb H155, and R&D goat pAb (Fig. 3; Fig. S2A-B; data not shown). Here, NANOG is linked to cancer.